Comparative Effects of Gongs and Maitland Mobilization in Patients With Adhesive Capsulitis

July 21, 2026 updated by: Riphah International University

Comparative Effects of Gongs and Maitland Mobilization on Pain, Range of Motion, and Functional Disability in Patients With Adhesive Capsulitis

Adhesive capsulitis is a common musculoskeletal disorder characterized by shoulder pain, restricted range of motion (ROM), and functional disability, leading to limitations in daily activities and reduced quality of life. Manual therapy techniques, including Gong's Mobilization and Maitland Mobilization, are widely used in physiotherapy management; however, evidence comparing their effectiveness remains limited.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The study aim to compare the effects of Gong's Mobilization and Maitland Mobilization on pain, shoulder range of motion, and functional disability in patients with adhesive capsulitis. A randomized clinical trial will be conducted on 60 participants diagnosed with stage II and III adhesive capsulitis. Participants will be randomly allocated into two groups: Gong's Mobilization and Maitland Mobilization. Both groups also received conventional physiotherapy, including hot pack application, stretching, isometric exercises, and a home exercise program. Outcome measures includes the Numeric Pain Rating Scale (NPRS), Shoulder Pain and Disability Index (SPADI), and shoulder ROM assessed using a goniometer. Assessments will be performed at baseline, Week 3, and Week 6. Data were analyzed using Mann-Whitney U and Friedman tests with a significance level of p ≤ 0.05.

Study Type

Interventional

Enrollment (Estimated)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged between 40-65 years.
  • Both male and female genders
  • Stage II and III frozen shoulder
  • Positive Apley's Scratch test
  • Pain rating 3 to 7 on NPRS for at least 3 months
  • Frozen shoulder with at least 25% restricted ROM

Exclusion Criteria:

  • Mental disorders
  • Arthritic shoulder
  • Rotator cuff disease
  • Post-traumatic stiff shoulder
  • Post-CABG shoulder-hand syndrome
  • Post-stroke frozen shoulder
  • Bilateral frozen shoulder
  • Neurological disorders
  • Frozen Shoulder secondary to Brachial Plexus Injury, Parkinsonism, Ankylosis, Infection, or Arthroplasty

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Gong's Mobilization
Group A will receive Gong's Mobilization for adhesive capsulitis.
Other: Group A: Gong's Mobilization
According to the criteria described by Gong et al., the patient was positioned in supine lying while the affected arm was placed upward to maintain the humerus in an upright position, with the elbow flexed to 90 degrees and the shoulder abducted to 90 degrees[A31.1]. The therapist then held the patient's hand and applied anterior-to-posterior pressure to the humerus while maintaining the elbow at a 90-degree angle. Subsequently, the therapist gently applied pressure to the articular capsule of the shoulder joint while elevating the patient's torso. The articular capsule was gently mobilized for 10-15 seconds followed by a 5-second release period. The therapist used one hand to perform medial rotation of the shoulder while stabilizing the elbow. This technique was performed for five sessions per week for four weeks, with 10-15 repetitions during each session
Active Comparator: Maitland Mobilization
Group B will receive Maitland Mobilization for adhesive capsulitis.
Other: Maitland Mobilization
Maitland mobilization using posterior glide technique was administered with the patient in a supine position. The therapist grasped the head of the humerus with one hand to perform the movements and stabilized the clavicular region with the other hand. The therapist remained in a standing position while applying the glides. To further stabilize the scapula and prevent scapular protraction, a towel was placed underneath the scapula, allowing smoother scapular glides[A.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale (NPRS)
Time Frame: upto 6 weeks
The Numeric Pain Rating Scale (NPRS) was a widely used tool designed to assess pain intensity in both clinical and research settings. It consisted of an 11-point scale ranging from 0 to 10, where 0 represented "no pain" and 10 indicated the "worst imaginable pain."
upto 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Goniometer
Time Frame: upto 6 weeks
The goniometer was a widely used instrument in clinical and rehabilitation settings to measure joint angles and assess the range of motion (ROM).
upto 6 weeks
Shoulder Pain and Disability Index (SPADI)
Time Frame: upto 6 weeks
The Shoulder Pain and Disability Index (SPADI) was a self-administered questionnaire designed to evaluate pain and functional impairment related to shoulder disorders. It consisted of 13 items divided into pain and disability subscales and was often used in both clinical practice and research.
upto 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Umama Irfan, MSPT*, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

December 30, 2026

Study Registration Dates

First Submitted

July 21, 2026

First Submitted That Met QC Criteria

July 21, 2026

First Posted (Actual)

July 24, 2026

Study Record Updates

Last Update Posted (Actual)

July 24, 2026

Last Update Submitted That Met QC Criteria

July 21, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/RCR & AHS/25/0139

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adhesive Capsulitis

Clinical Trials on Group A: Gong's Mobilization

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe